BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines scope 1 Direct GHG Emissions (tCO2e)
BeOne Responsible Business & Sustainability Reports (2019–2025)
Latest, FY2025
11,539
Period ended Dec 31, 2025
Change on a year earlier
+225.3%
3,547 in FY2024
History
7 years
Since FY2019
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Scope 1 Direct GHG Emissions (tCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11,539 | +225.3% | 2025 ESG Report ↗ |
| FY2024 | Dec 31, 2024 | 3,547 | +44.1% | 2025 ESG Report ↗ |
| FY2023 | Dec 31, 2023 | 2,462 | -27.4% | 2025 ESG Report ↗ |
| FY2022 | Dec 31, 2022 | 3,391 | +53.0% | 2024 ESG Report ↗ |
| FY2021 | Dec 31, 2021 | 2,217 | +349.7% | 2021 ESG Report ↗ |
| FY2020 | Dec 31, 2020 | 493 | -7.9% | 2021 ESG Report ↗ |
| FY2019 | Dec 31, 2019 | 535 | – | 2021 ESG Report ↗ |
Breakdown
What makes up scope 1 direct ghg emissions (tco2e)
Cite this data
StockData. (2026). BeOne Medicines Scope 1 Direct GHG Emissions (tCO2e), annual FY2019–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/esg_ghg_s1
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.